Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer—the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis

Increased glucose uptake mediated by glucose transporters and reliance on glycolysis are common features of malignant cells. Hypoxia-inducible factor-1α supports the adaptation of hypoxic cells by inducing genes related to glucose metabolism. The contribution of glucose transporter (GLUT) and hypoxia-inducible factor-1α (HIF-1α) activity to tumor behavior and their prognostic value in head and neck cancers remains unclear. The aim of this study was to examine the predictive value of GLUT1, GLUT3, and HIF-1α messenger RNA (mRNA)/protein expression as markers of tumor aggressiveness and prognosis in laryngeal cancer. The level of hypoxia/metabolic marker genes was determined in 106 squamous cell laryngeal cancer (SCC) and 73 noncancerous matched mucosa (NCM) controls using quantitative realtime PCR. The related protein levels were analyzed by Western blot. Positive expression of SLC2A1, SLC2A3, and HIF-1α genes was noted in 83.9, 82.1, and 71.7 % of SCC specimens and in 34.4, 59.4, and 62.5 % of laryngeal cancer samples. Higher levels of mRNA/protein for GLUT1 and HIF-1α were noted in SCC compared to NCM (p<0.05). SLC2A1 was found to have a positive relationship with grade, tumor front grading (TFG) score, and depth and mode of invasion (p<0.05). SLC2A3 was related to grade and invasion type (p<0.05). There were also relationships of HIF-1α with pTNM, TFG scale, invasion depth and mode, tumor recurrences, and overall survival (p<0.05). In addition, more advanced tumors were found to be more likely to demonstrate positive expression of these proteins. In conclusion, the hypoxia/metabolic markers studied could be used as molecular markers of tumor invasiveness in laryngeal cancer.This work was supported, in part, by the statutory fund of the Department of Cytobiochemistry, University of Łódź, Poland (506/811), and by grant fromtheNational Science Council, Poland (N403 043 32/2326)

Monocarbonyl Analogs of Curcumin Based on the Pseudopelletierine Scaffold: Synthesis and Anti-Inflammatory Activity

Curcumin (CUR) is a natural compound that exhibits anti-inflammatory, anti-bacterial, and other biological properties. However, its application as an effective drug is problematic due to its poor oral bioavailability, solubility in water, and poor absorption from the gastrointestinal tract. The aim of this work is to synthesize monocarbonyl analogs of CUR based on the 9-methyl-9-azabicyclo[3.2.1]nonan-3-one (pseudopelletierine, granatanone) scaffold to improve its bioavailability. Granatane is a homologue of tropane, whose structure is present in numerous naturally occurring alkaloids, e.g., L-cocaine and L-scopolamine. In this study, ten new pseudopelletierine-derived monocarbonyl analogs of CUR were successfully synthesized and characterized by spectral methods and X-ray crystallography. Additionally, in vitro test of the cytotoxicity and anti-inflammatory properties of the synthesized compounds were performed.This research received no external funding. Ramesh Gandusekar was supported by funds from the “ImPRESS” project of the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No 754432 and the Polish Ministry of Science and Higher Education through financial resources for science in 2018–2023 granted for the implementation of an international co-financed project.Damian Pawelski: [email protected] Walewska: [email protected] Ksiezak: [email protected] Sredzinski: [email protected] Radziwon: [email protected] Moniuszko: [email protected] Gandusekar: [email protected] Eljaszewicz: [email protected] Łaźny: [email protected] Brzezinski: [email protected] E. Plonska-Brzezinska: [email protected] Pawelski - Department of Organic Chemistry, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of BialystokAlicja Walewska - Department of Regenerative Medicine and Immune Regulation, Medical University of BialystokSylwia Ksiezak - Department of Regenerative Medicine and Immune Regulation, Medical University of BialystokDariusz Sredzinski - Regional Blood Donation and Blood Treatment Center in BialystokPiotr Radziwon - Regional Blood Donation and Blood Treatment Center in Bialystok; Department of Hematology, Medical University of BialystokMarcin Moniuszko - Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok; Department of Allergology and Internal Medicine, Medical University of BialystokRamesh Gandusekar - Department of Regenerative Medicine and Immune Regulation, Medical University of BialystokAndrzej Eljaszewicz - Department of Regenerative Medicine and Immune Regulation, Medical University of BialystokRyszard Łaźny - Faculty of Chemistry, University of BialystokKrzysztof Brzezinski - Department of Structural Biology of Prokaryotic Organisms, Institute of Bioorganic Chemistry, Polish Academy of SciencesMarta E. Plonska-Brzezinska - Department of Organic Chemistry, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of BialystokZhang, Z.-B.; Luo, D.-D.; Xie, J.-H.; Xian, Y.-F.; Lai, Z.-Q.; Liu, Y.-H.; Liu, W.-H.; Chen, J.-N.; Lai, X.-P.; Lin, Z.-X.; et al. Curcumin’s Metabolites, Tetrahydrocurcumin and Octahydrocurcumin, Possess Superior Anti-Inflammatory Effects in Vivo Through Suppression of TAK1-NF-KB Pathway. Front. Pharmacol. 2018, 9, 1181.Amalraj, A.; Pius, A.; Gopi, S.; Gopi, S. Biological Activities of Curcuminoids, Other Biomolecules from Turmeric and Their Derivatives—A Review. J. Trad. Compl. Med. 2017, 7, 205–233.Sandur, S.K.; Pandey, M.K.; Sung, B.; Ahn, K.S.; Murakami, A.; Sethi, G.; Limtrakul, P.; Badmaev, V.; Aggarwal, B.B. Curcumin, Demethoxycurcumin, Bisdemethoxycurcumin, Tetrahydrocurcumin and Turmerones Differentially Regulate Anti-Inflammatory and Anti-Proliferative Responses through a ROS-Independent Mechanism. Carcinogenesis 2007, 28, 1765–1773.Takagi, T.; Ramachandran, C.; Bermejo, M.; Yamashita, S.; Yu, L.X.; Amidon, G.L. A Provisional Biopharmaceutical Classification of the Top 200 Oral Drug Products in the United States, Great Britain, Spain, and Japan. Mol. Pharm. 2006, 3, 631–643.Wang, Y.-J.; Pan, M.-H.; Cheng, A.-L.; Lin, L.-I.; Ho, Y.-S.; Hsieh, C.-Y.; Lin, J.-K. Stability of Curcumin in Buffer Solutions and Characterization of Its Degradation Products. J. Pharm. Biomed. Anal. 1997, 15, 1867–1876.Brand-Williams, W.; Cuvelier, M.E.; Berset, C. Use of a Free Radical Method to Evaluate Antioxidant Activity. LWT-Food Sci. Tech. 1995, 28, 25–30.Feng, J.-Y.; Liu, Z.-Q. Phenolic and Enolic Hydroxyl Groups in Curcumin: Which Plays the Major Role in Scavenging Radicals? J. Agric. Food Chem. 2009, 57, 11041–11046.Somparn, P.; Phisalaphong, C.; Nakornchai, S.; Unchern, S.; Morales, N.P. Comparative Antioxidant Activities of Curcumin and Its Demethoxy and Hydrogenated Derivatives. Biol. Pharm. Bull. 2007, 30, 74–78.Sugiyama, Y.; Kawakishi, S.; Osawa, T. Involvement of the β-Diketone Moiety in the Antioxidative Mechanism of Tetrahydrocurcumin. Biochem. Pharm. 1996, 52, 519–525.Kiuchi, F.; Goto, Y.; Sugimoto, N.; Akao, N.; Kondo, K.; Tsuda, Y. Studies on Crude Drugs Effective on Visceral Larva Migrans. Part XVI. Nematocidal Activity of Turmeric: Synergistic Action of Curcuminoids. Chem. Pharm. Bull. 1993, 41, 1640–1643.Kumar, S.; Narain, U.; Tripathi, S.; Misra, K. Syntheses of Curcumin Bioconjugates and Study of Their Antibacterial Activities against β-Lactamase-Producing Microorganisms. Bioconjugate Chem. 2001, 12, 464–469.Pal, C.; Bandyopadhyay, U. Redox-Active Antiparasitic Drugs. Antioxid. Redox Sign. 2012, 17, 555–582.Pérez-Arriaga, L.; Mendoza-Magaña, M.L.; Cortés-Zárate, R.; Corona-Rivera, A.; Bobadilla-Morales, L.; Troyo-Sanromán, R.; Ramírez-Herrera, M.A. Cytotoxic Effect of Curcumin on Giardia Lamblia Trophozoites. Acta Trop. 2006, 98, 152–161.Jeong, G.-S.; Oh, G.-S.; Pae, H.-O.; Jeong, S.-O.; Kim, Y.-C.; Shin, M.-K.; Seo, B.Y.; Han, S.Y.; Lee, H.S.; Jeong, J.-G.; et al. Comparative Effects of Curcuminoids on Endothelial Heme Oxygenase-1 Expression: Ortho-Methoxy Groups Are Essential to Enhance Heme Oxygenase Activity and Protection. Exp. Mol. Med. 2006, 38, 393–400.Menon, V.P.; Sudheer, A.R. Antioxidant and anti-inflammatory properties of curcumin. In The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease; Aggarwal, B.B., Surh, Y.-J., Shishodia, S., Eds.; Advances in experimental medicine and biology; Springer: Boston, MA, USA, 2007; Volume 595, pp. 105–125. ISBN 978-0-387-46400-8.Lee, S.-Y.; Cho, S.-S.; Li, Y.; Bae, C.-S.; Park, K.M.; Park, D.-H. Anti-Inflammatory Effect of Curcuma Longa and Allium Hookeri Co-Treatment via NF-KB and COX-2 Pathways. Sci. Rep. 2020, 10, 5718.Allegra, A.; Innao, V.; Russo, S.; Gerace, D.; Alonci, A.; Musolino, C. Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies. Cancer Investig. 2017, 35, 1–22.Lee, H.S.; Ki, K.J.; Jae, Y.C.; Rhee, M.H.; Hong, S.; Kwon, M.; Kim, S.H.; Kang, S.Y. Neuroprotective Effect of Curcumin Is Mainly Mediated by Blockade of Microglial Cell Activation. Pharmazie 2007, 937–942.Bairwa, K.; Grover, J.; Kania, M.; Jachak, S.M. Recent Developments in Chemistry and Biology of Curcumin Analogues. RSC Adv. 2014, 4, 13946.Rossi, J.-F.; Lu, Z.Y.; Massart, C.; Levon, K. Dynamic Immune/Inflammation Precision Medicine: The Good and the Bad Inflammation in Infection and Cancer. Front. Immunol. 2021, 12, 595722.Black, P.H. Stress and the Inflammatory Response: A Review of Neurogenic Inflammation. Brain Behav. Immun. 2002, 16, 622–653.Stenvinkel, P.; Alvestrand, A. Review Articles: Inflammation in End-stage Renal Disease: Sources, Consequences, and Therapy. Semin. Dial. 2002, 15, 329–337.Jacob, A.; Wu, R.; Zhou, M.; Wang, P. Mechanism of the Anti-Inflammatory Effect of Curcumin: PPAR-γ Activation. PPAR Res. 2007, 2007, 1–5.Siddiqui, A.M.; Cui, X.; Wu, R.; Dong, W.; Zhou, M.; Hu, M.; Simms, H.H.; Wang, P. The Anti-Inflammatory Effect of Curcumin in an Experimental Model of Sepsis Is Mediated by up-Regulation of Peroxisome Proliferator-Activated Receptor-Γ*. Crit. Care Med. 2006, 34, 1874–1882.Saja, K.; Babu, M.S.; Karunagaran, D.; Sudhakaran, P.R. Anti-Inflammatory Effect of Curcumin Involves Downregulation of MMP-9 in Blood Mononuclear Cells. Intern. Immunopharm. 2007, 7, 1659–1667.Ung, V.Y.L.; Foshaug, R.R.; MacFarlane, S.M.; Churchill, T.A.; Doyle, J.S.G.; Sydora, B.C.; Fedorak, R.N. Oral Administration of Curcumin Emulsified in Carboxymethyl Cellulose Has a Potent Anti-Inflammatory Effect in the IL-10 Gene-Deficient Mouse Model of IBD. Dig. Dis. Sci. 2010, 55, 1272–1277.Funes, S.C.; Rios, M.; Fernández-Fierro, A.; Covián, C.; Bueno, S.M.; Riedel, C.A.; Mackern-Oberti, J.P.; Kalergis, A.M. Naturally Derived Heme-Oxygenase 1 Inducers and Their Therapeutic Application to Immune-Mediated Diseases. Front. Immunol. 2020, 11, 1467.Yadav, B.; Taurin, S.; Rosengren, R.J.; Schumacher, M.; Diederich, M.; Somers-Edgar, T.J.; Larsen, L. Synthesis and Cytotoxic Potential of Heterocyclic Cyclohexanone Analogues of Curcumin. Bioorganic Med. Chem. 2010, 18, 6701–6707.Revalde, J.L.; Li, Y.; Hawkins, B.C.; Rosengren, R.J.; Paxton, J.W. Heterocyclic Cyclohexanone Monocarbonyl Analogs of Curcumin Can Inhibit the Activity of ATP-Binding Cassette Transporters in Cancer Multidrug Resistance. Biochem. Pharm. 2015, 93, 305–317.Huber, I.; Rozmer, Z.; Gyöngyi, Z.; Budán, F.; Horváth, P.; Kiss, E.; Perjési, P. Structure Activity Relationship Analysis of Antiproliferative Cyclic C5-Curcuminoids without DNA Binding: Design, Synthesis, Lipophilicity and Biological Activity. J. Mol. Struc. 2020, 1206, 127661.Qiu, C.; Hu, Y.; Wu, K.; Yang, K.; Wang, N.; Ma, Y.; Zhu, H.; Zhang, Y.; Zhou, Y.; Chen, C.; et al. Synthesis and Biological Evaluation of Allylated Mono-Carbonyl Analogues of Curcumin (MACs) as Anti-Cancer Agents for Cholangiocarcinoma. Bioorganic Med. Chem. Lett. 2016, 26, 5971–5976.Liu, Z.; Sun, Y.; Ren, L.; Huang, Y.; Cai, Y.; Weng, Q.; Shen, X.; Li, X.; Liang, G.; Wang, Y. Evaluation of a Curcumin Analog as an Anti-Cancer Agent Inducing ER Stress-Mediated Apoptosis in Non-Small Cell Lung Cancer Cells. BMC Cancer 2013, 13, 494.Weng, Q.; Fu, L.; Chen, G.; Hui, J.; Song, J.; Feng, J.; Shi, D.; Cai, Y.; Ji, J.; Liang, G. Design, Synthesis, and Anticancer Evaluation of Long-Chain Alkoxylated Mono-Carbonyl Analogues of Curcumin. Eur. J. Med. Chem. 2015, 103, 44–55.Liang, G.; Shao, L.; Wang, Y.; Zhao, C.; Chu, Y.; Xiao, J.; Zhao, Y.; Li, X.; Yang, S. Exploration and Synthesis of Curcumin Analogues with Improved Structural Stability Both in Vitro and in Vivo as Cytotoxic Agents. Bioorganic Med. Chem. 2009, 17, 2623–2631.Zhao, C.; Liu, Z.; Liang, G. Promising Curcumin-Based Drug Design: Mono-Carbonyl Analogues of Curcumin (MACs). Curr. Pharm. Design 2013, 19, 2114–2135.Vasconcelos, T.; Sarmento, B.; Costa, P. Solid Dispersions as Strategy to Improve Oral Bioavailability of Poor Water Soluble Drugs. Drug Disc. Today 2007, 12, 1068–1075.Armstrong, D.W.; Han, S.M.; Han, Y.I. Separation of Optical Isomers of Scopolamine, Cocaine, Homatropine, and Atropine. Anal. Biochem. 1987, 167, 261–264.Huang, J.-P.; Wang, Y.-J.; Tian, T.; Wang, L.; Yan, Y.; Huang, S.-X. Tropane Alkaloid Biosynthesis: A Centennial Review. Nat. Prod. Rep. 2021.Anand, P.; Kunnumakkara, A.B.; Newman, R.A.; Aggarwal, B.B. Bioavailability of Curcumin: Problems and Promises. Mol. Pharm. 2007, 4, 807–818.Manju, S.; Sreenivasan, K. Conjugation of Curcumin onto Hyaluronic Acid Enhances Its Aqueous Solubility and Stability. J. Coll. Int. Sci. 2011, 359, 318–325.Chen, L.; Bai, G.; Yang, S.; Yang, R.; Zhao, G.; Xu, C.; Leung, W. Encapsulation of Curcumin in Recombinant Human H-Chain Ferritin Increases Its Water-Solubility and Stability. Food Res. Int. 2014, 62, 1147–1153.Ghosh, M.; Singh, A.T.K.; Xu, W.; Sulchek, T.; Gordon, L.I.; Ryan, R.O. Curcumin Nanodisks: Formulation and Characterization. Nanomed. Nanotechn. Biol. Med. 2011, 7, 162–167.Yen, F.-L.; Wu, T.-H.; Tzeng, C.-W.; Lin, L.-T.; Lin, C.-C. Curcumin Nanoparticles Improve the Physicochemical Properties of Curcumin and Effectively Enhance Its Antioxidant and Antihepatoma Activities. J. Agric. Food Chem. 2010, 58, 7376–7382.Mohanty, C.; Das, M.; Sahoo, S.K. Emerging Role of Nanocarriers to Increase the Solubility and Bioavailability of Curcumin. Expert Opin. Drug Deliv. 2012, 9, 1347–1364.Bhawana; Basniwal, R.K.; Buttar, H.S.; Jain, V.K.; Jain, N. Curcumin Nanoparticles: Preparation, Characterization, and Antimicrobial Study. J. Agric. Food Chem. 2011, 59, 2056–2061.Takahashi, M.; Uechi, S.; Takara, K.; Asikin, Y.; Wada, K. Evaluation of an Oral Carrier System in Rats: Bioavailability and Antioxidant Properties of Liposome-Encapsulated Curcumin. J. Agric. Food Chem. 2009, 57, 9141–9146.Margaritova Zaharieva, M.; Dimitrov Kroumov, A.; Dimitrova, L.; Tsvetkova, I.; Trochopoulos, A.; Mihaylov Konstantinov, S.; Reinhold Berger, M.; Momchilova, M.; Yoncheva, K.; Miladinov Najdenski, H. Micellar Curcumin Improves the Antibacterial Activity of the Alkylphosphocholines Erufosine and Miltefosine against Pathogenic Staphyloccocus Aureus Strains. Biotechnol. Biotechnol. Equip. 2019, 33, 38–53.Paramera, E.I.; Konteles, S.J.; Karathanos, V.T. Stability and Release Properties of Curcumin Encapsulated in Saccharomyces Cerevisiae, β-Cyclodextrin and Modified Starch. Food Chem. 2011, 125, 913–922.Pan, K.; Zhong, Q.; Baek, S.J. Enhanced Dispersibility and Bioactivity of Curcumin by Encapsulation in Casein Nanocapsules. J. Agric. Food Chem. 2013, 61, 6036–6043.Shimoda, K.; Hamada, H. Enzymatic Synthesis and Anti-Allergic Activities of Curcumin Oligosaccharides. Biochem. Insights 2010, 3, BCI–S2768.Gong, F.; Chen, D.; Teng, X.; Ge, J.; Ning, X.; Shen, Y.; Li, J.; Wang, S. Curcumin-Loaded Blood-Stable Polymeric Micelles for Enhancing Therapeutic Effect on Erythroleukemia. Mol. Pharm. 2017, 14, 2585–2594.Choudhury, A.; Raja, S.; Mahapatra, S.; Nagabhushanam, K.; Majeed, M. Synthesis and Evaluation of the Anti-Oxidant Capacity of Curcumin Glucuronides, the Major Curcumin Metabolites. Antioxidants 2015, 4, 750–767.Joe, B.; Vijaykumar, M.; Lokesh, B.R. Biological Properties of Curcumin-Cellular and Molecular Mechanisms of Action. Crit. Rev. Food Sci. Nutr. 2004, 44, 97–111.Huminiecki, L.; Horbańczuk, J.; Atanasov, A.G. The Functional Genomic Studies of Curcumin. Semin. Cancer Biol. 2017, 46, 107–118.Carolina Alves, R.; Perosa Fernandes, R.; Fonseca-Santos, B.; Damiani Victorelli, F.; Chorilli, M. A Critical Review of the Properties and Analytical Methods for the Determination of Curcumin in Biological and Pharmaceutical Matrices. Crit. Rev. Anal. Chem. 2019, 49, 138–149.Noureddin, S.A.; El-Shishtawy, R.M.; Al-Footy, K.O. Curcumin Analogues and Their Hybrid Molecules as Multifunctional Drugs. Eur. J. Med. Chem. 2019, 182, 111631.Rahman, A.F.M.M.; Ali, R.; Jahng, Y.; Kadi, A.A. A Facile Solvent Free Claisen-Schmidt Reaction: Synthesis of α,A0-Bis-(Substituted-Benzylidene)Cycloalkanones and α,A0-Bis-(Substituted-Alkylidene)Cycloalkanones. Molecules 2012, 17, 571–583.Wolosewicz, K.; Podgorska, K.; Rutkowska, E.; Lazny, R. Synthesis of Dicarbonyl Curcumin Analogues Containing the Tropane Scaffold: Synthesis of Dicarbonyl Curcumin Analogues Containing the Tropane Scaffold. Eur. J. Org. Chem. 2019, 2019, 4662–4674.Medley, J.W.; Movassaghi, M. Robinson’s Landmark Synthesis of Tropinone. Chem. Commun. 2013, 49, 10775.Afewerki, S.; Wang, J.-X.; Liao, W.-W.; Córdova, A. The Chemical Synthesis and Applications of Tropane Alkaloids. In The Alkaloids: Chemistry and Biology; Elsevier: Amsterdam, The Netherlands, 2019; Volume 81, pp. 151–233. ISBN 978-0-12-817151-6.Kamarul Zaman, M.A.; Mohamad Azzeme, A. Plant Toxins: Alkaloids and Their Toxicities. GSC Biol. Pharm. Sci. 2018, 6, 021–029.Velema, W.A.; Kietrys, A.M.; Kool, E.T. RNA Control by Photoreversible Acylation. J. Am. Chem. Soc. 2018, 140, 3491–3495.Pace, R.D.; Regmi, Y. The Finkelstein Reaction: Quantitative Reaction Kinetics of an SN2 Reaction Using Nonaqueous Conductivity. J. Chem. Educ. 2006, 83, 1344.Petrov, O.; Ivanova, Y.; Gerova, M. SOCl2/EtOH: Catalytic System for Synthesis of Chalcones. Cat. Comm. 2008, 9, 315–316.Das, B.; Thirupathi, P.; Mahender, I.; Reddy, K.R. Convenient and Facile Cross-Aldol Condensation Catalyzed by Molecular Iodine: An Efficient Synthesis of α,A0-Bis(Substituted-Benzylidene) Cycloalkanones. J. Mol. Cat. A Chem. 2006, 247, 182–185.Li, J.; Su, W.; Li, N. Copper Triflate–Catalyzed Cross-Aldol Condensation: A Facile Synthesis of α,A0-Bis(Substituted Benzylidene) Cycloalkanones. Synt. Comm. 2005, 35, 3037–3043.Motiur Rahman, A.F.M.; Jeong, B.-S.; Kim, D.H.; Park, J.K.; Lee, E.S.; Jahng, Y. A Facile Synthesis of α,A0-Bis(SubstitutedBenzylidene)-Cycloalkanones and Substituted-Benzylidene Heteroaromatics: Utility of NaOAc as a Catalyst for Aldol-Type Reaction. Tetrahedron 2007, 63, 2426–2431.George, H.; Roth, H.J. Photoisomerisierung und Cyclo-1,2-Addition α, β-ungesättigter Cyclanone. Tetrahedron Lett. 1971, 12, 4057–4060.Chen, Z.; Izenwasser, S.; Katz, J.L.; Zhu, N.; Klein, C.L.; Trudell, M.L. Synthesis and Dopamine Transporter Affinity of 2- (Methoxycarbonyl)-9-Methyl-3-Phenyl-9-Azabicyclo[3.3.1]Nonane Derivatives. J. Med. Chem. 1996, 39, 4744–4749.Nodzewska, A.; Bokina, A.; Romanowska, K.; Lazny, R. Environmentally Benign Diastereoselective Synthesis of Granatane and Tropane Aldol Derivatives. RSC Adv. 2014, 4, 29668.Dolomanov, O.V.; Bourhis, L.J.; Gildea, R.J.; Howard, J.A.K.; Puschmann, H. OLEX2: A Complete Structure Solution, Refinement and Analysis Program. J. Appl. Crystallogr. 2009, 42, 339–341.Sheldrick, G.M. SHELXT–Integrated Space-Group and Crystal-Structure Determination. Acta Crystallogr. A Found Adv. 2015, 71, 3–8.Sheldrick, G.M. Crystal Structure Refinement with SHELXL. Acta Crystallogr. C Struct. Chem. 2015, 71, 3–8.Spek, A.L. Structure Validation in Chemical Crystallography. Acta Crystallogr. D Biol. Crystallogr. 2009, 65, 148–155.222112

Comparative study of fungal cell disruption—scope and limitations of the methods

Simple and effective protocols of cell wall disruption were elaborated for tested fungal strains: Penicillium citrinum, Aspergillus fumigatus, Rhodotorula gracilis. Several techniques of cell wall disintegration were studied, including ultrasound disintegration, homogenization in bead mill, application of chemicals of various types, and osmotic shock. The release of proteins from fungal cells and the activity of a cytosolic enzyme, glucose-6-phosphate dehydrogenase, in the crude extracts were assayed to determine and compare the efficacy of each method. The presented studies allowed adjusting the particular method to a particular strain. The mechanical methods of disintegration appeared to be the most effective for the disintegration of yeast, R. gracilis, and filamentous fungi, A. fumigatus and P. citrinum. Ultrasonication and bead milling led to obtaining fungal cell-free extracts containing high concentrations of soluble proteins and active glucose-6-phosphate dehydrogenase systems

Prostaglandin D2-supplemented “functional eicosanoid testing and typing” assay with peripheral blood leukocytes as a new tool in the diagnosis of systemic mast cell activation disease: an explorative diagnostic study

Background: Systemic mast cell activation disease (MCAD) is characterized by an enhanced release of mast cell-derived mediators, including eicosanoids, which induce a broad spectrum of clinical symptoms. Accordingly, the diagnostic algorithm of MCAD presupposes the proof of increased mast cell mediator release, but only a few mediators are currently established as routine laboratory parameters. We thus initiated an explorative study to evaluate in vitro typing of individual eicosanoid pattern of peripheral blood leukocytes (PBLs) as a new diagnostic tool in MCAD. Methods: Using the “functional eicosanoid testing and typing” (FET) assay, we investigated the balance (i.e. the complex pattern of formation, release and mutual interaction) of prostaglandin E2 (PGE2) and peptido-leukotrienes (pLT) release from PBLs of 22 MCAD patients and 20 healthy individuals. FET algorithms thereby consider both basal and arachidonic acid (AA)-, acetylsalicylic acid (ASA)-, and substance P (SP)-triggered release of PGE2 and pLT. The FET assay was further supplemented by analyzing prostaglandin D2 (PGD2), as mast cell-specific eicosanoid. Results: We observed marked PGE2-pLT imbalances for PBLs of MCAD patients, as indicated by a markedly enhanced mean FET value of 1.75 ± 0.356 (range: 1.14–2.36), compared to 0.53 ± 0.119 (range: 0.36-0.75) for healthy individuals. In addition, mean PGD2 release from PBLs of MCAD patients was significantly, 6.6-fold higher than from PBLs of healthy individuals (946 ± 302.2 pg/ml versus 142 ± 47.8 pg/ml; P < 0.001). In contrast to healthy individuals, PGD2 release from PBLs of MCAD patients was markedly triggered by SP (mean: 1896 ± 389.7 pg/ml; P < 0.001), whereas AA and ASA caused individually varying effects on both PGD2 and pLT release. Conclusions: The new in-vitro FET assay, supplemented with analysis of PGD2, demonstrated that the individual patterns of eicosanoid release from PBLs can unambiguously distinguish MCAD patients from healthy individuals. Notably, in our analyses, the FET value and both basal and triggered PGD2 levels were not significantly affected by MCAD-specific medication. Thus, this approach may serve as an in-vitro diagnostic tool to estimate mast cell activity and to support individualized therapeutic decision processes for patients suffering from MCAD

The 42nd Symposium Chromatographic Methods of Investigating Organic Compounds : Book of abstracts

The 42nd Symposium Chromatographic Methods of Investigating Organic Compounds : Book of abstracts. June 4-7, 2019, Szczyrk, Polan

RP-18 TLC chromatographic and computational study of skin permeability of steroids

The skin permeability of steroids, as investigated in this study, is important because some of these compounds are, or could, be used in preparations applied topically. Several models of skin permeability, involving thin layer chromatographic and calculated descriptors, were generated and validated using&nbsp;Kp&nbsp;reference values obtained in silico and then tested on a group of solutes whose experimental&nbsp;Kp&nbsp;values could be found (log&nbsp;Kpexp). The study established that the most applicable log&nbsp;Kp&nbsp;model is based on RP-18 thin layer chromatographic data (RM) and the calculated descriptors&nbsp;VM&nbsp;(molar volume) and&nbsp;PSA&nbsp;(polar surface area). Two less efficient, yet simple, equations based on&nbsp;PSA&nbsp;or&nbsp;VM&nbsp;combined with&nbsp;HD&nbsp;(H-donor count) can be used with caution for rapid, rough estimations of compounds&rsquo; skin permeability prior to their chemical synthesis.</p

Peroral administration of triiodothyronine (T 3

International audienc